Pfizer announced on Friday that its experimental oral pill for COVID-19, PAXLOVID, helps reduce the rate of hospitalisation and death by 89 percent. The development is part of worldwide efforts
Tag "oral COVID-19 pill"
Advertisement
Advertisement
Advertisement
Advertisement
Top Stories
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Life and Living
Advertisement
Advertisement